Mecklenburg Jennifer, Patil Mayur J, Koek Wouter, Akopian Armen N
Department of Endodontics, School of Dentistry, UT Health Science Center, San Antonio, TX, USA.
Department of Psychiatry, School of Medicine, UT Health Science Center, San Antonio, TX, USA.
Pain Rep. 2017 Jan;2(1):e584. doi: 10.1097/PR9.0000000000000584.
Suboptimal management of postoperative pain leads to increased risk of chronic opioid therapy, especially in elderly patients.
Although this age-dependent phenomenon has been observed clinically, basic mechanisms including baseline nociception, postoperative hypersensitivity, and mu-opioid efficiency in aged animals have never been evaluated.
We tested these criteria using incision model on adult (3–6 months) and aged (24 months) mice to assess translatability of postoperative animal studies to clinical observations.
Thermal and mechanical testing revealed lower baseline nociception in aged vs adult mice, while behavioral assays after hind paw plantar incision showed similar hypersensitivity levels for both age groups. Efficiency of local and spinal mu-opioid injections on postoperative pain was assessed next. DAMGO, a pure mu-opioid, was effective in reducing postoperative hypersensitivity in aged and adult mice, although adult mice displayed increased sensitivity to higher doses (50 μg local; 1–15 μg spinal). Buprenorphine, a mixed mu-opioid agonist, produced dose-dependent antihypersensitivity with adult mice more sensitive to lower doses (0.1 μg local; 0.02 μg spinal), and aged mice more sensitive to higher doses (1, 10 μg local; 0.1, 1 μg spinal). Finally, exploratory locomotor activity was used to evaluate the suppression of incision-induced spontaneous pain by DAMGO. Spinal and systemic (intraperitoneal) DAMGO inhibited ongoing pain more in adults compared with aged mice.
As in humans, baseline nociception was lower in aged vs adult mice, while postoperative hypersensitivity magnitudes were comparable between groups. Unlike in humans, adult mice were more sensitive to mu-opioids, although higher doses of mixed mu-opioids were more effective for postoperative antihypersensitivity in aged mice.
术后疼痛管理欠佳会增加慢性阿片类药物治疗的风险,尤其是在老年患者中。
尽管这种年龄依赖性现象在临床上已被观察到,但老年动物的基线伤害感受、术后超敏反应和μ-阿片类药物效能等基本机制从未被评估过。
我们在成年(3 - 6个月)和老年(24个月)小鼠上使用切口模型测试这些标准,以评估术后动物研究与临床观察结果的可转化性。
热刺激和机械刺激测试显示,老年小鼠的基线伤害感受低于成年小鼠,而后足跖部切口后的行为学分析表明,两个年龄组的超敏反应水平相似。接下来评估了局部和脊髓注射μ-阿片类药物对术后疼痛的效果。纯μ-阿片类药物DAMGO可有效减轻老年和成年小鼠的术后超敏反应,尽管成年小鼠对较高剂量(局部50μg;脊髓1 - 15μg)更为敏感。混合μ-阿片类激动剂丁丙诺啡产生剂量依赖性抗超敏反应,成年小鼠对较低剂量(局部0.1μg;脊髓0.02μg)更敏感,而老年小鼠对较高剂量(局部1、10μg;脊髓0.1、1μg)更敏感。最后,利用探索性运动活动来评估DAMGO对切口诱导的自发疼痛的抑制作用。与老年小鼠相比,脊髓和全身(腹腔内)注射DAMGO对成年小鼠持续疼痛的抑制作用更强。
与人类一样,老年小鼠的基线伤害感受低于成年小鼠,而两组之间的术后超敏反应程度相当。与人类不同的是,成年小鼠对μ-阿片类药物更敏感,尽管较高剂量的混合μ-阿片类药物对老年小鼠的术后抗超敏反应更有效。